Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $34.66 million. The enterprise value is $29.42 million.

Market Cap	34.66M
Enterprise Value	29.42M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

SER has 10.66 million shares outstanding. The number of shares has increased by 72.47% in one year.

Current Share Class	10.66M
Shares Outstanding	10.66M
Shares Change (YoY)	+72.47%
Shares Change (QoQ)	+3.35%
Owned by Insiders (%)	12.23%
Owned by Institutions (%)	4.39%
Float	5.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	274.66
Forward PS	n/a
PB Ratio	21.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	253.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 2.12.

Current Ratio	1.31
Quick Ratio	0.98
Debt / Equity	2.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-684.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-137.85%
Return on Invested Capital (ROIC)	-971.25%
Return on Capital Employed (ROCE)	-603.97%
Revenue Per Employee	$8,923
Profits Per Employee	-$1.45M
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-43.48%
50-Day Moving Average	4.55
200-Day Moving Average	5.16
Relative Strength Index (RSI)	32.35
Average Volume (20 Days)	17,837

Short Selling Information

The latest short interest is 63,378, so 0.59% of the outstanding shares have been sold short.

Short Interest	63,378
Short Previous Month	69,282
Short % of Shares Out	0.59%
Short % of Float	1.22%
Short Ratio (days to cover)	2.40

Income Statement

In the last 12 months, SER had revenue of $116,000 and -$18.80 million in losses. Loss per share was -$1.92.

Revenue	116,000
Gross Profit	-12.00M
Operating Income	-21.89M
Pretax Income	-18.63M
Net Income	-18.80M
EBITDA	-21.78M
EBIT	-21.89M
Loss Per Share	-$1.92

Full Income Statement

Balance Sheet

The company has $8.62 million in cash and $3.39 million in debt, giving a net cash position of $5.23 million or $0.49 per share.

Cash & Cash Equivalents	8.62M
Total Debt	3.39M
Net Cash	5.23M
Net Cash Per Share	$0.49
Equity (Book Value)	1.59M
Book Value Per Share	-0.30
Working Capital	2.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.51 million and capital expenditures -$64,000, giving a free cash flow of -$16.58 million.

Operating Cash Flow	-16.51M
Capital Expenditures	-64,000
Free Cash Flow	-16.58M
FCF Per Share	-$1.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-18,868.97%
Pretax Margin	-16,061.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-72.47%
Shareholder Yield	-72.47%
Earnings Yield	-54.25%
FCF Yield	-47.82%

Analyst Forecast

The average price target for SER is $13.00, which is 300.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	300.00%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.60%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SER has an Altman Z-Score of -9.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.42
Piotroski F-Score	2